“…Despite the limitations of quinoid compounds, anthracyclines, and other agents such as doxorubicin, idarubicin, aclarubicin, and naphthazarin, because of their life-threatening cardiomyopathy upon chronic administration, they still provide significant anti-inflammation or antioxidation functions (Anufriev et al, 1998;Kourounakis et al, 2002). Among the 1,4-naphthoquinones, two interesting structures are 2-and 6-substituted 5,8-dihydroxy-1,4-naphthoquinone (DHNQ) derivatives because they have significant cytotoxic and aintitumor activities (Baik et al, 1997).…”